Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Atlantic Union Bankshares A Pref | AUB-A | Nov 29, 2024 | 25.64 | +2.33 |
Atlantica Sustainable Infrastructure | AY | Nov 29, 2024 | 21.94 | -0.99 |
Atlanticus | ATLC | Nov 29, 2024 | 58.26 | -0.80 |
Atlanticus B Pref | ATLCP | Nov 29, 2024 | 24.00 | -0.33 |
Atlas Energy Solutions | AESI | Nov 29, 2024 | 23.57 | +0.64 |
Atlas Lithium | ATLX | Nov 29, 2024 | 7.09 | -0.70 |
Atlas Pref D | ATCO-D | Nov 29, 2024 | 25.24 | +0.96 |
Atlas Pref H | ATCO-H | Nov 29, 2024 | 25.18 | +1.12 |
AtlasClear Holdings | ATCH | Nov 29, 2024 | 0.22 | +9.99 |
Atlassian A | TEAM | Nov 29, 2024 | 263.58 | +0.43 |
Atmos Energy | ATO | Nov 29, 2024 | 151.32 | -0.07 |
Atmus Filtration Technologies | ATMU | Nov 29, 2024 | 43.29 | +0.53 |
ATN International | ATNI | Nov 29, 2024 | 19.78 | -1.98 |
Atomera | ATOM | Nov 29, 2024 | 6.18 | +5.82 |
Atossa Therapeutics | ATOS | Nov 29, 2024 | 1.30 | +1.56 |
Atour Lifestyle ADR | ATAT | Nov 29, 2024 | 25.15 | +1.29 |
ATRenew A ADR | RERE | Nov 29, 2024 | 3.29 | -4.36 |
AtriCure | ATRC | Nov 29, 2024 | 36.16 | -0.03 |
ATS Corporation | ATS | Nov 29, 2024 | 32.69 | +5.49 |
aTyr Pharma | ATYR | Nov 29, 2024 | 3.53 | +2.62 |
Auburn National Bank | AUBN | Nov 29, 2024 | 23.00 | -2.54 |
Auddia | AUUD | Nov 29, 2024 | 0.58 | +5.15 |
AudioCodes | AUDC | Nov 29, 2024 | 9.30 | +2.20 |
AudioEye | AEYE | Nov 29, 2024 | 26.92 | +0.45 |
Auna S.A.A | AUNA | Nov 29, 2024 | 7.19 | -0.28 |
Aura Biosciences | AURA | Nov 29, 2024 | 9.31 | +3.44 |
Aura FAT Projects Acquisition A | AFAR | Nov 29, 2024 | 11.68 | 0.00 |
Aurinia Pharmaceuticals | AUPH | Nov 29, 2024 | 8.86 | +0.11 |
Aurora Cannabis | ACB | Nov 29, 2024 | 4.55 | +0.22 |
Aurora Innovation A | AUR | Nov 29, 2024 | 6.47 | -0.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.